Aug.01,2024

Updated "Research and Development Pipeline."

Aug.01,2024

Consolidated Financial Results(1Q/Apr-Jun FY2024)

Jun.19,2024

Zeria Pharmaceutical and Agastra-Lab announces reaching Agreement for the Development of Acotiamide.

May.09,2024

Updated "Research and Development Pipeline."

May.09,2024

Consolidated Financial Results (for the Fiscal Year Ended March 31, 2024)